editors, David O. Azorsa, Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, Arizona, USA ; Shilpi Arora, Constellation Pharmaceuticals, Cambridge, Massachusetts, USA.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
New York :
Name of Publisher, Distributor, etc.
Humana Press,
Date of Publication, Distribution, etc.
[2016]
SERIES
Series Title
Methods in molecular biology,
Series Title
Springer protocols
Volume Designation
1470
ISSN of Series
1064-3745 ;
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
SUMMARY OR ABSTRACT
Text of Note
High-throughput RNAi screening remains one of the most widely used technologies to perform target identification and validation studies in an unbiased manner. These assays are equally important for research and development across academic, biotech, and pharmaceutical industries.--
TOPICAL NAME USED AS SUBJECT
High throughput screening (Drug development), Laboratory manuals.